BRTX - Company ID 0001505497
BioRestorative Therapies, Inc. (BRTX) reported net income of -$14.24M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$14.24M | -58.6% |
| FY 2024 | -$8.98M | +13.8% |
| FY 2023 | -$10.42M | +21.2% |
| FY 2022 | -$13.22M | +70.2% |
| FY 2021 | -$44.30M | -293.0% |
| FY 2020 | -$11.27M | +23.0% |
| FY 2019 | -$14.65M | -17.0% |
| FY 2018 | -$12.52M | -32.5% |
| FY 2017 |
BioRestorative Therapies, Inc. (BRTX) reported net income of -$14.24M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, BioRestorative Therapies, Inc.'s net income declined from -$4.07M to -$14.24M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$9.44M |
| -9.4% |
| FY 2016 | -$8.64M | -9.0% |
| FY 2015 | -$7.92M | -41.8% |
| FY 2014 | -$5.59M | +2.8% |
| FY 2013 | -$5.75M | +12.0% |
| FY 2012 | -$6.54M | -60.5% |
| FY 2011 | -$4.07M | - |